Holdings
Saratoga Health & Biotechnology Fund
As of May 31, 2026, Saratoga Health & Biotechnology Fund reported 27 positions worth US$10.4M. Largest: Cardinal Health, Inc., Jazz Pharmaceuticals Plc and United Therapeutics Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cardinal Health, Inc. | 3,429 | US$675K | no change | May 31, 2026 |
| Jazz Pharmaceuticals Plc | 2,741 | US$648K | −500 | May 31, 2026 |
| United Therapeutics Corporation | 1,160 | US$646K | no change | May 31, 2026 |
| Amgen Inc. | 1,567 | US$528K | −185 | May 31, 2026 |
| Mckesson Corporation | 691 | US$513K | no change | May 31, 2026 |
| Lantheus Holdings, Inc. | 4,900 | US$487K | no change | May 31, 2026 |
| Exelixis, Inc. | 9,445 | US$477K | +1,500 | May 31, 2026 |
| Novartis Ag | 3,147 | US$472K | −12 | May 31, 2026 |
| Cencora, Inc. | 1,683 | US$453K | no change | May 31, 2026 |
| Gilead Sciences, Inc. | 3,068 | US$412K | no change | May 31, 2026 |